Temporal and spacial expression of perlecan in dental pulp after injury

Abstract

Abstract: PURPOSE: To investigate the temporal and special expressions and functions of perlecan in dental pulp of rats after injury. METHODS: Specimens of one side of maxillary molars of 24 male SD rats were collected 1,3,5,7 days after injury, and the other side were used as controls. The specimens were decalcified and embedded in paraffin, sliced by longitudinal section and stained by immunohistochemistry. The staining of perlecan and β1 integrin were examined, and the average optical density (AOD) was compared. The measurement data were analyzed by ANOVA using SPSS 19.0 software package. RESULTS: The staining intensity of perlecan in dental pulp in the experimental group was significantly higher compared with that of the control group. The immunolocalization of perlecan in dental pulp was gradually progressed as the inflamed tissue was progressing after injury, and its AOD was significantly higher than that of control group (F=11.104,P<0.05), especially in the group of 1 d. The staining of β1 integrin was generally enhanced in the pulp 3 d after injury, and its AOD was significantly higher than that of control group (F=124.18,P<0.05). CONCLUSIONS: Perlecan may play an important role in tissue defense mechanism after injury through regulating angiogenesis and inflammatory cell infiltration.

Key words: Perlecan, β1 integrin, Immunohistochemistry, Rat, Dental pulp injury

CLC Number:

R781.3

LI Qiao, SUN Hong, PAN Yi-huai, LIU Chuan-tong. Temporal and spacial expression of perlecan in dental pulp after injury[J]. Shanghai Journal of Stomatology, 2014, 23(1): 15-19.

References

[1] Whitelock JM, Melrose J, Iozzo RV. Diverse cell signaling events modulated by perlecan [J]. Biochemistry, 2008, 47(43): 11174-11183.
[2] Zoeller JJ, McQuillan A, Whitelock J, et al. A central function for perlecan in skeletal muscle and cardiovascular development [J]. J Cell Biol, 2008, 181(2): 381-394.
[3] Pitol DL, Caetano FH, Lunardi LO. Microwave-induced fast decalcification of rat bone for electron microscopic analysis: an ultrastructural and cytochemical study[J].Braz Dent J,2007,18(2): 153-157.
[4] Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis[J]. J Cell Mol Med,2011,15(5): 1013-1031.
[5] Ida-Yonemochi H, Ohshiro K, Swelam W, et al. Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum [J]. J Histochem Cytochem, 2005, 53(6): 763-772.
[6] Ida-Yonemochi H, Satokata I, Ohshima H, et al. Morphogenetic roles of perlecan in the tooth enamel organ: an analysis of overexpression using transgenic mice[J]. Matrix Biol,2011,30(7-8): 379-388.
[7] 陆群, 郭敬俊, 吴补领, 等. 胶质源性神经营养因子在正常和炎症牙髓组织中的变化 [J]. 牙体牙髓牙周病学杂志, 2000, 10(4): 201-203.
[8] García de Yébenes E, Ho A, Damani T, et al. Regulation of the heparan sulfate proteoglycan, perlecan, by injury and interleukin-1alpha [J]. J Neurochem, 1999, 73(2): 812-820.
[9] Leadbeater WE, Gonzalez AM, Logaras N, et al. Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex [J]. J Neurochem, 2006, 96(4): 1189-1200.
[10] Hauser PJ, Dozmorov MG, Bane BL, et al. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis [J]. J Urol, 2008, 179(2): 764-769.
[11] Tran PK, Agardh HE, Tran-Lundmark K, et al. Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions [J]. Atherosclerosis,2007,190(2): 264-270.
[12] Tran-Lundmark K, Tran PK, Paulsson-Berne G, et al. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation[J]. Circ Res, 2008, 103(1): 43-52.
[13] Aviezer D, Hecht D, Safran M, et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis [J]. Cell, 1994, 79(6): 1005-1013.
[14] Ichimaru Y, Krimmer DI, Burgess JK, et al. TGF-β enhances deposition of perlecan from COPD airway smooth muscle [J]. Am J Physiol Lung Cell Mol Physiol, 2012, 302(3): L325-333.
[15] Soulez M, Sirois I, Brassard N, et al. Epidermal growth factor and perlecan fragments produced by apoptotic endothelial cells co-ordinately activate ERK1/2-dependent antiapoptotic pathways in mesenchymal stem cells [J]. Stem Cells, 2010, 28(4): 810-820.